Mylan Launches Generic Aromasin® Tablets supriya kashyap kashyap17 March 2017 11:52 AM IST England : Mylan N.V. announced the U.S. launch of Exemestane Tablets, 25 mg, a generic version of the reference listed drug, Pfizer's Aromasin®...
Glenmark's Ankleshwar plant gets EIR report from USFDA supriya kashyap kashyap16 March 2017 11:30 AM ISTNew Delhi : Drug firm Glenmark has received establishment inspection report (EIR) from the US health regulator on closure of inspection of its...
Amgen's Repatha lowers need for cholesterol lowering procedure supriya kashyap kashyap16 March 2017 11:30 AM ISTAmgen Inc said its injection Repatha significantly reduced the need for patients to undergo a procedure to reduce bad cholesterol, according to the...
Sun Pharma says FDA to lift ban on Mohali drug plant savita thakur thakur16 March 2017 11:28 AM ISTMUMBAI - India's largest drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday that U.S. regulators plan to lift a ban on its Mohali plant in...
Plaintiffs in US lawsuit say Monsanto ghostwrote Roundup studies supriya kashyap kashyap16 March 2017 11:28 AM ISTEmployees of Monsanto Co ghostwrote scientific reports that U.S. regulators relied on to determine that a chemical in its Roundup weed killer does not...
Govt gets Rs 672 crore fine from pharma cos for overcharging savita thakur thakur15 March 2017 11:09 AM ISTNew Delhi: Drug pricing regulator NPPA has received Rs 672.28 crore fine till date from pharmaceutical companies for overcharging, Parliament was...
Ackman sells Valeant stake, takes 3 billion dollars loss savita thakur thakur15 March 2017 11:00 AM ISTBOSTON: Billionaire investor William Ackman walked away from Valeant Pharmaceuticals International Inc with a loss of more than $3 billion as he sold...
Amgen's Repatha lowers need for cholesterol lowering procedure supriya kashyap kashyap14 March 2017 10:56 AM ISTData that should help unlock the sales potential of a potent new cholesterol medicine will be unveiled at the American College of Cardiology meeting...
Belgium's Tigenix says heart attack stem cell trial successful supriya kashyap kashyap14 March 2017 10:54 AM ISTBelgian biotech group Tigenix said its medical trial with a novel treatment for patients at risk of heart failure after a coronary attack was...
Mylan deal clears path for biosimilar copy of Roche's Herceptin supriya kashyap kashyap14 March 2017 10:53 AM ISTLondon : Generic drug maker Mylan said it had reached a settlement with Roche providing "a clear pathway" for the launch of its biosimilar version of...
FDA approves Novartis drug as first-line treatment for breast cancer supriya kashyap kashyap14 March 2017 10:53 AM ISTNovartis AG said that the U.S. Food and Drug Administration had approved the company's experimental drug, kisqali, as a first-line treatment for a...
Glenmark Pharmaceuticals and Evestra, Inc. Announce Partnership Agreement for Generic NuvaRing supriya kashyap kashyap13 March 2017 11:21 AM ISTMumbai : Glenmark Pharmaceuticals Inc., USA, and Evestra, Inc. have completed a strategic development, license and commercialization agreement to...
